Mid-Year Report

RICCHETTI INCORPORATED for NOVARTIS

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

issues related to the PDUFA reauthorization (Prescription Drug User Fee Authorization Act) issues related to drug importation (Prescription Drug Affordability Act, H.R. 194, Pharmaceutical Market Access and Safety Drug Act, S. 242, H.R. 380)

LobbyistCovered position, as disclosed
LUKE ALBEE N/A
JEFF RICCHETTI N/A
STEVE RICCHETTI N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 242 (110th), H.R. 194 (110th), H.R. 380 (110th)

Advertising ADV

Issues relating to direct-to-consumer marketing of prescription drugs (FDA Amendments Act, HR 2900, S. 1082)

LobbyistCovered position, as disclosed
LUKE ALBEE N/A
JEFF RICCHETTI N/A
STEVE RICCHETTI N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1082 (110th), H.R. 2900 (110th)

Copyright/Patent/Trademark CPT

issues related to the Patent Reform Act (S. 1145, HR 1908)

LobbyistCovered position, as disclosed
LUKE ALBEE N/A
JEFF RICCHETTI N/A
STEVE RICCHETTI N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Medicare/Medicaid MMM

issues related to CHAMP (Children's Health and Medicare Protection Act)

LobbyistCovered position, as disclosed
LUKE ALBEE N/A
JEFF RICCHETTI N/A
STEVE RICCHETTI N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.